ANIMAL PHYSIOLOGICAL AREAS

Pet — dogs and cats

Feline and canine cell models: the in vitro tests used to document the effect of an ingredient or a supplement for companion animals, on the species it is intended for.

PET

Animal areas

Farm animalsPet — dogs and cats

What you can demonstrate here

In pet food the owner buys as they would buy for themselves, and asks for the same proof they expect from their own supplements. The model makes the difference: data obtained on feline cells or canine fibroblasts is worth something else entirely compared with data borrowed from the human field. Here we work on the right species, and where the comparison with competitors is the real question, the study is set up as a comparative one.

The data in the species that will use it. When an ingredient already has human data, we repeat the same design on dog and cat cells: same concentrations, same markers, same controls. The veterinary results then read alongside the human ones.

The models we use

Canine (DH82) and feline (Fcwf-4) macrophagesFeline respiratory cellsCanine fibroblastsReconstructed three-dimensional skinHepatic cellsCanine intestinal epitheliumPrimary canine and feline bladder epithelial cellsCanine aortic endothelial cellsCanine plasmaPathogenic strains and biofilm modelsChemical and analytical methods

What we measure

Skin and repair
  • Wound healing on canine fibroblasts and reconstructed 3D skin
  • Anti-inflammatory activity on skin and intestinal models
  • MIC determination, synergy with methicillin and biofilm disruption
Immune defences and airways
  • Immunostimulant action on feline immune cells
  • Anti-inflammatory action on feline respiratory cells
  • IL-6 modulation in LPS-stimulated canine and feline macrophages, with the same marker as the human studies
Stomach and intestine
  • Protective effect on gastric cells at species-specific pH
  • Anti-inflammatory activity on intestinal epithelium
  • Restoration of intestinal barrier integrity
  • Prebiotic activity and resistance to gastrointestinal digestion
  • Paracellular permeability of canine intestinal epithelium after LPS-induced inflammatory damage, with a positive protection control
  • IL-8 release after LPS stimulation, also read on the same wells as the barrier test
Liver and oxidative stress
  • Cytoprotection of hepatic cells from induced oxidative stress
  • Antioxidant activity on hepatic cells and keratinocytes
Joint and pain
  • Toxicological, anti-inflammatory and antioxidant profile on joint models
  • Analgesic activity on neuronal cells
Heart and circulation
  • Verification of the activity of single ingredients and of blend synergy on veterinary cardiovascular models
  • Permeability of canine endothelium, for ingredients acting on oedema and microcirculation
  • Assays on canine plasma
Urinary tract
  • Bactericidal activity (MBC) and antibiofilm activity on E. coli and P. aeruginosa, with biofilm readings confirmed by colony counts
  • Anti-inflammatory activity on primary canine and feline bladder epithelial cells
  • Anti-adhesion of uropathogenic E. coli to bladder epithelium
  • Comparison between a new formulation and the one on the market, with the same method
Oral cavity
  • Antibiofilm activity for oral products for dogs and cats, such as gels and chews
Bioavailability and analytical methods
  • Species-specific simulated gastrointestinal digestion and quantification of the active
  • Intestinal absorption on Caco-2
  • Identification and quantification of probiotic strains

What is measured in this area

Feline and canine cell models: the endpoints that document the effect of an ingredient for companion animals, on the species it is meant for.

  • Urinary tract — bactericidal, anti-inflammatory and anti-adhesion activity on the species’ bladder epithelium
  • Oral cavity — biofilm of oral products for dogs and cats
  • Species compatibility — cell viability on feline and canine models; markers assayed with species-specific ELISAs
  • Gut barrier — epithelial tightness in the target species
  • Dog and cat microbiota — selective growth on the animal’s own flora
  • Simulated digestion — bioaccessibility of the ingredient under species conditions
  • Inflammatory response — mediators released by the epithelium under stimulus
  • Oxidative stress — reactive species and cellular defences
  • Pathogen adhesion — the effect on attachment of microorganisms to the epithelium
  • Functional markers — additional endpoints according to the function the product has to support

What you receive

  • A report with model, protocol, controls and raw data
  • Results per replicate, with mean and spread declared
  • Results on cells of the species the product is intended for
  • A comparison across the concentrations tested, to guide the dosage
  • A readable comparison between the conditions tested, usable in a technical dossier or in a conversation with a downstream customer

Who it is for, and where to start

How we can bring you value

You develop an ingredientand you want evidence your customers can useIngredient validation and valorisation
You develop a finished productand you want to know what stays active in the formulationSupplement valorisation and formulation development

Shall we talk about it?

Tell us about the product and what you need to show: we will tell you which models and which tests the case calls for.

Write to us

Tell us about your project

Write to us here: the division team will get back to you.